| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 07/06/2006 | CA2591912A1 Pyrimidinylisoxazole derivatives |
| 07/06/2006 | CA2587348A1 Organic compounds |
| 07/05/2006 | EP1676918A2 G-beta-gamma regulated phosphatidylinositol-3' kinase |
| 07/05/2006 | EP1676912A2 Medical equipment containing a polypeptide having heparanase activity |
| 07/05/2006 | EP1676855A2 Prenyl transferase inhibitors |
| 07/05/2006 | EP1676846A2 Hydantoin derivatives as MMP inhibitors |
| 07/05/2006 | EP1676845A1 New quinazoline derivatives |
| 07/05/2006 | EP1676839A2 Novel beta crystalline form of perindopril tert-butylamine salt, its preparation method and pharmaceutical compositions containing same |
| 07/05/2006 | EP1676602A1 Continuous administration of epitopes derived from protein present in atherosclerotic plaque for the treatment of atherosclerosis |
| 07/05/2006 | EP1676570A1 Topical pharmaceutical compositions comprising L-arginine and uses thereof |
| 07/05/2006 | EP1675862A1 New 2-substituted, 4-amino-thiazolo 4,5-d pyrimidines, useful as chemokine receptor antagonists, esp. cx3cr1 |
| 07/05/2006 | EP1675834A1 Compounds, compositions, and methods |
| 07/05/2006 | EP1675552A2 Preperation of 1,6-disubstituted azabenzimidazoles as kinase inhibitors |
| 07/05/2006 | EP1675547A2 Glucocerebroside treatment of disease |
| 07/05/2006 | EP1675459A1 Use of boranocarbonates for the therapeutic delivery of carbon monoxide |
| 07/05/2006 | EP1490360A4 Thiazolidinedione derivatives and pharmaceutical composition comprising the same |
| 07/05/2006 | EP1399441B1 N-aroyl cyclic amine derivatives as orexin receptor antagonists |
| 07/05/2006 | EP1377575B1 Antiviral pyrazolopyridine compounds |
| 07/05/2006 | EP1250328B1 Dihydro-1,3,5-triazine amine derivatives and their therapeutic uses |
| 07/05/2006 | EP1067958B1 Treatment of cardiac hypertrophy |
| 07/05/2006 | CN1798975A Method of screening drug with the use of 67 KDA laminin receptor and drug obtained thereby |
| 07/05/2006 | CN1798831A Compositions comprising lactobacillus plantarum strains in combination with tannin and new lactobacillus plantarum strains |
| 07/05/2006 | CN1798769A Antibodies to masp-2 |
| 07/05/2006 | CN1798746A Reverse-turn mimetics and method relating thereto |
| 07/05/2006 | CN1798732A Substituted tetralins and indanes |
| 07/05/2006 | CN1798564A Topical blood pressure composition |
| 07/05/2006 | CN1798554A Use of fibrates for the preparation of a medicament useful in the treatment of congestive heart failure |
| 07/05/2006 | CN1796397A Technique for preparing pharmaceutical product of í«Denghuayisuí» in high purity |
| 07/05/2006 | CN1796390A 9a,11 ¿C dinitrogen ¿C acene [b] fluorenone,preparation method and application in preparing medication |
| 07/05/2006 | CN1796388A Sesamin/episesamin compositions |
| 07/05/2006 | CN1796370A Compound substitution heterocycle class |
| 07/05/2006 | CN1795927A Composite of total flavone phospholipid of safflower, and preparation method |
| 07/05/2006 | CN1795919A Honeyed pills of pure Chinese traditional medicine for reducing blood fat and decreasing blood pressure |
| 07/05/2006 | CN1795912A Chinese traditional medicine for resisting atherosclerosis |
| 07/05/2006 | CN1795905A Medication for treating hyperosteogeny and complicating disease |
| 07/05/2006 | CN1795900A Soft capsule of acetic acid of hawkthorn, and preparation method |
| 07/05/2006 | CN1795898A Chinese traditional medicine for treating coronary heart disease |
| 07/05/2006 | CN1795894A Freeze drying powder injection of compound red sange root, and preparation method |
| 07/05/2006 | CN1795891A Composite of total flavone phosphatide of astragalus, and preparation method |
| 07/05/2006 | CN1795887A Chinese traditional medicine preparation for treating heart disease and preparation method |
| 07/05/2006 | CN1795885A Liposome of Kudiezi and preparation method |
| 07/05/2006 | CN1795881A Composite of total flavone phosphatide of seabuckthorn, and preparation method |
| 07/05/2006 | CN1795879A Method for preparing extractive of low acidic gingko leaves |
| 07/05/2006 | CN1795869A Drop pills of hippophase rhamnoides and preparation method |
| 07/05/2006 | CN1795736A Quick dissolving roselle tea bag |
| 07/05/2006 | CN1262551C Substituted oxazolidinones and their use in the field of blood coagulation |
| 07/05/2006 | CN1262541C Tricyclic protein kinase inhibitors |
| 07/05/2006 | CN1262299C Chinese medicine adhesive film for preventing and treating coronary heart disease and angina pectoris and its preparing method |
| 07/05/2006 | CN1262295C Health care medicine capable of strengthening heart and kidney function and immunologic function |
| 07/05/2006 | CN1262294C Ginseng and aconite injection liquid for treating qi vacuity and yang desertion and its preparation method |
| 07/05/2006 | CN1262291C Medicine for treating diabetes and its vascular complications and preparation method thereof |
| 07/05/2006 | CN1262284C Health care product of hippophae rhamnoides oil |
| 07/05/2006 | CN1262283C Compound preparation of purslane extraction and ginsenoside and its anti-anoxia usage |
| 07/05/2006 | CN1262280C Medicine and health-care product formed from ganglioside and ginkgo leaf extract and their application |
| 07/05/2006 | CN1262277C Injection of low molecular weight chondroitin sulfate and its preparation method |
| 07/05/2006 | CN1262212C Health care beverage |
| 07/04/2006 | US7071359 Neuropathy improvers containing nitrogenous compounds as the active ingredient |
| 07/04/2006 | US7071358 Lipid diseases; metabolism diosrders; antiproliferative agents |
| 07/04/2006 | US7071349 Purification method of N-(1(S)-ethoxycarbonyl-3-phenylpropyl)-L-alanine |
| 07/04/2006 | US7071344 Vitamin D derivatives with cyclopropyl rings in the lateral chains, a method and intermediate products for the production thereof and the utilization thereof for producing medicaments |
| 07/04/2006 | US7071335 2-pyridinyl-1-piperazine therapeutic agents useful for treating pain |
| 07/04/2006 | US7071332 Indolinone derivatives as protein kinase/phosphatase inhibitors |
| 07/04/2006 | US7071300 IGF antagonist peptides |
| 07/04/2006 | US7071221 Heterocyclic oxime compounds |
| 07/04/2006 | US7071213 Cannabinoid receptor ligands |
| 07/04/2006 | US7071212 N-(4-carbamimidoyl-phenyl)-glycine derivatives |
| 07/04/2006 | US7071210 Mixtures of cholesteryl ester transfer protein (CETP) inhibitor such as torcetrapib and calcium channel blockers, angiotensin converting enzyme inhibitors, diuretics or adrenergic blocking agents use for cardiovascular disorders |
| 07/04/2006 | US7071207 Suppression appetite; induction weight loss |
| 07/04/2006 | US7071202 Compositions and formulations of 9-nitrocamptothecin polymorphs and methods of use therefor |
| 07/04/2006 | US7071191 Non-imidazole aryloxypiperidines |
| 07/04/2006 | US7071185 Treating schizophrenia with no weight-gain side effects; 5-HT2c recptor agonist; bipolar disorder; antidepressants; anxiolytic agents; panic attack; agoraphobia; antiepileptic agents; sleep disorders; migraines; sexual dysfunction |
| 07/04/2006 | US7071183 Use of inhibitors of the renin-angiotensin system |
| 07/04/2006 | US7071179 Method of locking 1α-OH of vitamin D compounds in axial orientation |
| 07/04/2006 | US7071175 Pyridine mercapto carboxylic acids as carboxypeptidase U inhibitors |
| 07/04/2006 | US7071170 Bactericides; antiprotozoa agents |
| 07/04/2006 | US7071169 Pyrane derivatives as both ACE-and NEP-inhibitors |
| 07/04/2006 | US7071160 Integrin binding polipeptide for diagnosis, prevention and treatment of renal failure, thrombosis, osteoporosis, cancers and diabetes |
| 07/04/2006 | US7071159 Solubility forms; skin disorders, rheumatic disorders, antidiabetic agents |
| 07/04/2006 | US7071158 Antioxidant enhancement of therapy for hyperproliferative conditions |
| 07/04/2006 | US7070971 enzyme inhibitor for selectin mediated binding events and methods of treating disease conditions using animal models; genetic engineering |
| 07/04/2006 | US7070814 Plant extracts for treatment of cancer |
| 07/04/2006 | US7070805 Comprises a pharmacologically active ingredient, a sugar and a low-substituted hydroxypropylcellulose having 5 to 7% by weight of hydroxypropyl group; fast disintegrability, suitable strength and no roughness |
| 07/04/2006 | US7070792 Chlamydia antigens and corresponding DNA fragments and uses thereof |
| 07/04/2006 | CA2404848C Indole carboxylic acids as thyroid receptor ligands |
| 07/04/2006 | CA2364719C 2-aminopyridines containing fused ring substituents |
| 07/04/2006 | CA2332066C Tetrazole compounds as thyroid receptor ligands |
| 07/04/2006 | CA2264721C A1 adenosine receptor antagonists |
| 07/04/2006 | CA2233285C Pyrazolopyrimidines as crf receptor antagonists |
| 06/29/2006 | WO2006069202A2 Compositions comprising anti-igf-i receptor antibodies and methods for obtaining said antibodies |
| 06/29/2006 | WO2006069125A1 Indazole-carboxamide compounds |
| 06/29/2006 | WO2006068988A1 Combination therapy for vascular complications associated with hyperglycemia |
| 06/29/2006 | WO2006068326A1 Novel polypeptide and the use thereof |
| 06/29/2006 | WO2006068199A1 Metabolically stable 3-oxy-1,2,4-triazole derivatives |
| 06/29/2006 | WO2006068117A1 Preventive for nephropathy and food having the function imparted thereto |
| 06/29/2006 | WO2006067913A1 Method of preparing antibody by use of cell having its fucose transporter function inhibited |
| 06/29/2006 | WO2006067868A1 Arterial sclerosis preventive agent |
| 06/29/2006 | WO2006067856A1 Functional food or pharmaceutical and process for producing the same |
| 06/29/2006 | WO2006067847A1 Method of preparing antibody by use of cell having its fucose transporter function inhibited |
| 06/29/2006 | WO2006067601A1 Oral pharmaceutical compositions of irbesartan and hydrochlorothiazide and processes for their preparation |
| 06/29/2006 | WO2006067472A1 Parp inhibitors |